11 research outputs found

    Membranas finas soportadas de polĂ­mero PEBAX para la eliminaciĂłn de diĂłxido de carbono de corrientes de gas natural y biogĂĄs

    Get PDF
    El objetivo principal de este trabajo es la fabricación de membranas finas de polímero sobre soporte asimétrico poliimida-P84 e incorporación de MOFs (metal organic frameworks) en la matriz polimérica. Estas membranas se han preparado para la separación de la mezcla de gases CO2/CH4, por lo que deben ser selectivas y permeables

    Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Get PDF
    Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    Thin supported MOF based mixed matrix membranes of PebaxÂź 1657 for biogas upgrade

    No full text
    This work shows the preparation of thin mixed matrix membranes (MMMs) with a 2–3 ÎŒm thick PebaxÂź 1657 layer on two different supports: a porous asymmetric polyimide P84Âź and dense polytrimethylsilylpropyne (PTMSP). Nanoparticles of metal–organic frameworks (MOFs) ZIF-8, MIL-101(Cr), UiO-66 and ZIF-7/8 core–shells were selected as fillers for the PebaxÂź 1657 based MMMs, all of them being MOFs with high CO2 adsorption capacity but different pore size distribution. All the membranes were characterized by SEM, FTIR, Raman, TGA and XRD analyses, showing in all cases a perfect compatibility of the PebaxÂź layer with both supports and also a good dispersion of the fillers in the polymeric matrix. These membranes were applied for the separation of equimolar CO2/CH4 mixtures at 35 °C under feed pressures between 3 and 5 bar, where an improvement in the gas separation performance with increasing pressure was noticed, thanks to the favored solubility of CO2. The synergistic compatibility between PebaxÂź 1657 and P84Âź gave rise to a 470% enhancement in CO2/CH4 selectivity, reaching a maximum value of 114 while the CO2 permeance increased by 40% up to 7.5 GPU. The addition of fillers in the PebaxÂź polymeric phase produced an improvement in the gas separation performance of the membranes, especially in terms of permeance, where the MMMs containing a 10 wt% loading of UiO-66 reached the optimum value of 11.5 GPU of CO2 (together with a CO2/CH4 selectivity of 55.6).Financial support from the Spanish MINECO and FEDER (MAT2016-77290-R), the Aragon Government (T43-17R) and the ESF is gratefully acknowledged. J. S.-L. thanks the Spanish Education Ministry Program FPU2014 for his PhD grant.Peer reviewe

    Discovering HIV related information by means of association rules and machine learning

    Get PDF
    Acquired immunodeficiency syndrome (AIDS) is still one of the main health problems worldwide. It is therefore essential to keep making progress in improving the prognosis and quality of life of affected patients. One way to advance along this pathway is to uncover connections between other disorders associated with HIV/AIDS-so that they can be anticipated and possibly mitigated. We propose to achieve this by using Association Rules (ARs). They allow us to represent the dependencies between a number of diseases and other specific diseases. However, classical techniques systematically generate every AR meeting some minimal conditions on data frequency, hence generating a vast amount of uninteresting ARs, which need to be filtered out. The lack of manually annotated ARs has favored unsupervised filtering, even though they produce limited results. In this paper, we propose a semi-supervised system, able to identify relevant ARs among HIV-related diseases with a minimal amount of annotated training data. Our system has been able to extract a good number of relationships between HIV-related diseases that have been previously detected in the literature but are scattered and are often little known. Furthermore, a number of plausible new relationships have shown up which deserve further investigation by qualified medical experts

    Microrelatario

    No full text
    Basta/Prou es el resultado de El desafío por la erradicación de la violencia contra las mujeres que el Instituto Universitario de Estudios Feministas y de Género Purificación Escribano de la Universitat Jaume I lanzó en los Diez días contra la violencia de género 2012
    corecore